Universitätsklinikum Essen

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy (2026) Möhn N, Grote-Levi L, Bonifacius A, Tischer-Zimmermann S, Nay S, Jendretzky KF, Sassmann ML, et al. Journal article Current treatment decisions in cardiac transthyretin amyloidosis: a multicentre analysis (2026) Lavall D, Knoll K, Spethmann S, Hahn K, Barzen G, Winzer EB, Jellinghaus S, et al. Journal article Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland (2026) Simon L, Vucinic V, Rejeski K, Schubert ML, Aydilek E, Wagner-Drouet EM, Penack O, et al. Journal article Guidelines for Neuroprognostication in Critically Ill Adults with Status Epilepticus (2026) Madzar D, Rajajee V, Muehlschlegel S, Wartenberg KE, Alexander SA, Busl KM, Creutzfeldt CJ, et al. Journal article Randomized Comparison of Cardiotoxicity With 60 Versus 90 mg Daunorubicin in AML Induction Therapy (2026) Dendorfer SM, Schmidt-Brücken K, Kramer M, Steffen B, Schliemann C, Mikesch JH, Alakel N, et al. Journal article Melanoma of unknown primary shows an oncogenic pattern and clinical course of sun-exposed melanoma. (2026) Lodde G, Dollani J, Galetzka W, Mohr P, Meier F, Gutzmer R, Weichenthal M, et al. Journal article Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura (2026) Kühne L, Osterholt T, Suer M, Cukoski S, Wendt R, Pfrepper C, Petros S, et al. Journal article A Retrospective, Multicenter Analysis Within the National Network Genomic Medicine Lung Cancer in Germany to Detect RET Fusions as a Possible Mechanism of Resistance in Patients With EGFR Mutations (2026) Kropf-Sanchen C, Frost N, Kuon J, Wermke M, Krüger S, Fuchs F, Wiesweg M, et al. Journal article Frontline Pembrolizumab or Methotrexate in Elderly, Frail, or Cisplatin-Ineligible Patients with Relapsed or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of the Randomized Phase 2 Study ELDORANDO (AIO-KHT-0115). (2026) Klinghammer K, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al. Journal article Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM) (2025) Kalkavan H, Scheulen ME, Kämpgen E, Keilholz U, Heinzerling L, Lueong SS, Hlinka A, et al. Journal article